Your browser doesn't support javascript.
loading
Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after COPD Hospitalization among Older Adults.
Mosher, Christopher L; Osazuwa-Peters, Oyomoare L; Nanna, Michael G; MacIntyre, Neil R; Que, Loretta G; Jones, Schuyler; Palmer, Scott M; O'Brien, Emily C.
Affiliation
  • Mosher CL; Duke University School of Medicine, Durham, North Carolina, United States; christopher.mosher@duke.edu.
  • Osazuwa-Peters OL; Duke University School of Medicine, Durham, North Carolina, United States.
  • Nanna MG; Yale School of Medicine, New Haven, Connecticut, United States.
  • MacIntyre NR; Duke University Hospital, Durham, North Carolina, United States.
  • Que LG; Duke University Medical Center, Medicine, Durham, North Carolina, United States.
  • Jones S; Duke University School of Medicine, Durham, North Carolina, United States.
  • Palmer SM; Duke University, Medicine - Pulmonary, Allergy, and Critical Care, Durham, North Carolina, United States.
  • O'Brien EC; Duke Clinical Research Institute, Durham, North Carolina, United States.
Ann Am Thorac Soc ; 2024 Jul 17.
Article in En | MEDLINE | ID: mdl-39018486
ABSTRACT

BACKGROUND:

Meta-analyses have suggested the risk of cardiovascular disease (CVD) events is significantly higher after a chronic obstructive pulmonary disease (COPD) exacerbation. However, many of these studies have included a broad array of CVD events or have been limited to highly selected patient populations potentially not generalizable to the broader population of COPD.

METHODS:

We assessed the risk of atherosclerotic cardiovascular disease (ASCVD)hospitalizations after COPD hospitalization compared to before COPD hospitalization and identified patient factors associated with ASCVD hospitalizations after COPD hospitalization. This retrospective cohort study used claims data from 920,550 Medicare beneficiaries hospitalized for COPD from 2016-2019 in the US. The primary outcome was risk of a ASCVD hospitalization composite outcome (myocardial infarction, percutaneous coronary intervention, coronary artery by-pass graft surgery, stroke, or transient ischemic attack) in the 30-days and 1 year after-COPD hospitalization relative to the same time period before-COPD hospitalization. Time in the before- and after-COPD hospitalization time periods to a composite ASCVD hospitalization outcome were modeled using an extension of the Cox Proportional-Hazards model, the Anderson-Gill model with adjustment for patient characteristics. Additional analyses evaluated for interactions in subgroups associated with the composite ASCVD hospitalization outcome.

RESULTS:

Among 920,550 patients in the 30-day and 1-year cohorts, (mean age, 73-74 years) the hazard ratio estimate (HR; 95% CI) for the composite ASCVD hospitalization outcome after-COPD hospitalization vs before-COPD hospitalization for the 30-day cohort was 0.99 (0.93, 1.05; p = 0.67) and for the 1-year cohort was 0.99 (0.97, 1.02; p = 0.53) following adjustment. We observed 3 subgroups that were significantly associated with higher risk for ASCVD hospitalizations 1 year after COPD hospitalization 76+ years old, women, COPD hospitalization severity.

CONCLUSION:

Among Medicare beneficiaries hospitalized for COPD, the risk of ASCVD hospitalizations was not significantly increased 30-day or 1-year after COPD-hospitalization relative to before-COPD hospitalization. In sub-group analyses, we identified age 76+ years old, female sex, and COPD hospitalization severity as high risk subgroups with increased risk of ASCVD events 1-year after-COPD hospitalization. Further research is needed to characterize the COPD exacerbation populations at highest ASCVD hospitalization risk.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Am Thorac Soc Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Am Thorac Soc Year: 2024 Document type: Article Country of publication: United States